Menu

Corner cutting compromises clinical trials: the inherent problems with up-front randomisation and a common standard arm

By Hills R.K., Richards S.M., Wheatley K. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Ribonucleotide reductase: an old target with new potential

By Smith B.D., Karp J.E. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Phase I and pharmacodynamic study of Triapine ( R), a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia

By Giles F.J., Fracasso P.M., Kantarjian H.M., Cortes J.E., Brown R.A., Verstovsek S., Alvarado Y., Thomas D.A., Faderl S., Garcia-Manero G., Wright L.P., Samson T., Cahill A., Lambert P., Plunkett W., Sznol M., DiPersio J.F., Gandhi V. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study

By Cherry A.M., Brockman S.R., Paternoster S.F., Hicks G.A., Neuberg D., Higgins R.R., Bennett J.M., Greenberg P.L., Miller K., Tallman M.S., Rowe J., Dewald G.W. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase

By Giles F.J., Feldman E.J., Roboz G.J., Larson R.A., Mamus S.W., Cortes J.E., Verstovsek S., Faderl S., Talpaz M., Beran M., Albitar M., O'Brien S.M., Kantarjian H.M. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma - A pilot study

By Xiros N., Economopoulos T., Valsami S., Rontogianni D., Fountzilas G., Raptis S. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Molecular evidence for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemia

By Kollia P., Samara M., Stamatopoulos K., Belessi C., Stavroyianni N., Tsompanakou A., Athanasiadou A., Vamvakopoulos N., Laoutaris N., Anagnostopoulos A., Fassas A. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Low dose daily rhGM-CSF application activates monocytes and dendritic cells in vivo

By Demir G., Klein H.O., Tuzuner N. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia

By Ozgen U., Turkoz Y., Stout M., Ozugurlu F., Pelik F., Bulut Y., Aslan M., Ravindranath Y., Savasan S. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite

Relationship between cyclin D1 and p21 Waf1/Cip1 during differentiation of human myeloid leukemia cell lines

By Ullmannova V., Stockbauer P., Hradcova M., Soucek J., Haskovec C. in (2003)

Elsevier

Abstract Access to resources Recommend Favorite